/Companies

Negev Labs

1 known investors

Find your way into Negev Labs

Sign up to see every warm intro you have to Negev Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Negev Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Palomar Labs (formerly Negev Labs) is a venture studio that rediscovers overlooked drugs with prior human exposure, secures new IP around better indications or formulations, and builds a company around each asset, focused on late-life neuropsychiatric disease. Its programs include investigational therapies for apathy in Parkinson's disease, late-life depression, and agitation/aggression in neurodegeneration.

Investors · 1

Frequently asked questions

What does Negev Labs do?
Palomar Labs (formerly Negev Labs) is a venture studio that rediscovers overlooked drugs with prior human exposure, secures new IP around better indications or formulations, and builds a company around each asset, focused on late-life neuropsychiatric disease. Its programs include investigational therapies for apathy in Parkinson's disease, late-life depression, and agitation/aggression in neurodegeneration.
Who are Negev Labs's investors?
Negev Labs's investors include Tetrad.